Vote Scores
Filings read through

Intra-Cellular Therapies, Inc.: how funds voted at the meeting of 27 Mar 2025

Meeting
Season
year to 30 June 2025
Filers reporting
540
Ballot items
6

540 filers on Form N-PX reported votes at the Intra-Cellular Therapies, Inc. meeting of 27 Mar 2025. The records fall into 6 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Intra-Cellular Therapies, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Advisory vote on executive pay (say-on-pay)

    747 vote records from 522 filers. 253 of the 495 filers that marked the item voted against management. 27 filers gave no management mark.

    • Positions of 46 fund families
    • For 18
    • Against 27
    • Split or no vote 1
    • Against management 25
  2. Item 2: Advisory vote on pay tied to a merger or sale

    11 vote records from 10 filers. 7 of the 8 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of one fund family
    • Against 1
    • Against management 1
  3. Item 3: EXTRAORDINARY TRANSACTIONS: management items

    The company's items in this category are shown together, because filers word and number them differently.

    241 vote records from 133 filers. 0 of the 132 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 38 fund families
    • For 38
  4. Item 4: COMPENSATION: management items

    The company's items in this category are shown together, because filers word and number them differently.

    10 vote records from 9 filers. 1 of the 8 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 2 fund families
    • For 2
  5. Item 5: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    339 vote records from 159 filers. 12 of the 158 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 41 fund families
    • For 39
    • Against 2
    • Against management 2
  6. Item 6: Shareholder proposals (not separable from the filings)

    • Proposed by a security holder
    • Several categories

    Filers described these proposals in different words that the site could not match, so they are shown together.

    1 vote record from 1 filer. 1 of the 1 filer that marked the item voted against management.

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Intra-Cellular Therapies, Inc., meeting of 27 Mar 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family1. Say-on-pay2. Merger pay
AllianceBernsteinAgainst, against managementNo report
AllspringAgainst, against managementNo report
American CenturyAgainst, against managementNo report
BlackRock and iSharesForNo report
BNY MellonAgainst, against managementNo report
Brighthouse FundsAgainstNo report
Capital Group and American FundsSplitNo report
Charles SchwabForNo report
Columbia ThreadneedleAgainst, against managementNo report
DimensionalAgainst, against managementNo report
DWSAgainst, against managementNo report
EquitableAgainst, against managementNo report
FidelityAgainst, against managementNo report
First TrustAgainst, against managementNo report
Franklin TempletonForNo report
Goldman SachsAgainst, against managementNo report
Guggenheim and RydexAgainst, against managementNo report
Hartford FundsForNo report
InvescoForNo report
J.P. MorganAgainst, against managementAgainst, against management
Jackson National fundsForNo report
Janus HendersonAgainst, against managementNo report
John Hancock and ManulifeAgainst, against managementNo report
Lincoln FinancialAgainstNo report
Macquarie and Delaware FundsAgainst, against managementNo report
MassMutualForNo report
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementNo report
NationwideForNo report
Natixis and Loomis SaylesForNo report
Neuberger BermanForNo report
Northern Trust and FlexSharesAgainst, against managementNo report
Nuveen and TIAAAgainst, against managementNo report
Pacific Life fundsForNo report
PGIM and PrudentialForNo report
PrincipalForNo report
ProShares and ProFundsAgainst, against managementNo report
Russell InvestmentsForNo report
SEIForNo report
State Street and SPDRForNo report
T. Rowe PriceAgainst, against managementNo report
TransamericaAgainst, against managementNo report
VanguardForNo report
Victory CapitalAgainst, against managementNo report
VirtusForNo report
VoyaAgainst, against managementNo report
WisdomTreeAgainst, against managementNo report

Questions

How many filers reported votes at the Intra-Cellular Therapies, Inc. meeting?
540 Form N-PX filers reported votes at the meeting of 27 Mar 2025. On say-on-pay, 253 of 495 filers that marked the item voted against management (51.1%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Intra-Cellular Therapies, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Intra-Cellular Therapies, Inc. with a meeting date within three days of 27 Mar 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .